Clinical and cost implications of target joints in Canadian boys with severe hemophilia A.

[1]  V. Blanchette,et al.  A survey of factor prophylaxis in boys with haemophilia followed in North American haemophilia treatment centres , 2003, Haemophilia : the official journal of the World Federation of Hemophilia.

[2]  V. Blanchette,et al.  Health‐related quality‐of‐life treatments for severe haemophilia: utility measurements using the Standard Gamble technique , 2002, Haemophilia : the official journal of the World Federation of Hemophilia.

[3]  F. Beek,et al.  Long‐term outcome of individualized prophylactic treatment of children with severe haemophilia , 2001, British journal of haematology.

[4]  J. Astermark,et al.  Primary prophylaxis in severe haemophilia should be started at an early age but can be individualized , 1999, British journal of haematology.

[5]  B. Evatt,et al.  Occurrence of hemophilia in the United States , 1998 .

[6]  J. Avorn,et al.  Prophylactic Use of Factor VIII: an Economic Evaluation , 1998, Thrombosis and Haemostasis.

[7]  W. Ribbans,et al.  Conservative treatment of hemarthrosis for prevention of hemophilic synovitis. , 1997, Clinical orthopaedics and related research.

[8]  J. Lusher.  Prophylaxis in Children with Hemophilia: Is it the Optimal Treatment? , 1997, Thrombosis and Haemostasis.

[9]  S. Teutsch,et al.  Episodic versus prophylactic infusions for hemophilia A: a cost-effectiveness analysis. , 1996, The Journal of pediatrics.

[10]  H. Pettersson,et al.  A longitudinal study of orthopaedic outcomes for severe factor‐VIII‐deficient haemophiliacs , 1994, Journal of internal medicine.

[11]  H. Pettersson,et al.  Twenty‐five years' experience of prophylactic treatment in severe haemophilia A and B , 1992, Journal of internal medicine.

[12]  P. Newacheck,et al.  Childhood chronic illness: prevalence, severity, and impact. , 1992, American journal of public health.

[13]  R. Ljung,et al.  Prophylactic treatment of severe hemophilia A and B can prevent joint disability , 1994 .

[14]  J J Stoddard,et al.  Prevalence and impact of multiple childhood chronic illnesses. , 1994, The Journal of pediatrics.

[15]  M. Blombäck,et al.  Prophylaxis with factor concentrates in preventing hemophilic arthropathy. , 1991, The American journal of pediatric hematology/oncology.

[16]  Lusher Jm.  Assessment of response to treatment and design of clinical trials. , 1984 .